• News
  • SAN DIEGO
  • Health

OncoSec Medical promotes new CFO

San Diego-based OncoSec Medical Inc. (OTC: ONCS) has promoted company Vice President and Controller Veronica Vallejo to CFO.

Vallejo has more than 15 years of public accounting experience and has worked for nearly a decade in a senior management position.

Vallejo holds a bachelor's degree in business administration with an emphasis in accounting from San Diego State University. She is a certified public accountant and a member of the American Institute of Certified Public Accountants.

“Veronica has been an integral part of our team since the inception of OncoSec, and this promotion is well-deserved,” said Punit Dhillon, president and CEO. “Her strategic insights and strong financial acumen will be valuable to the future success and growth of the company.”

OncoSec Medical is a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers.

RELATED ARTICLES:

OncoSec Medical announces $7.2M public offering

OncoSec Medical gets key patent from China

Tri-City names new VP of IT

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

OncoSec Medical Inc.

Company Website

4690 Executive Dr. Ste., 250
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ONCS
4.31
  0.25  
+ 6.16%
128,643,000
13.19
3.37

OncoSec Medical Inc. Executive(s):

Punit Dhillon

  • Chief Executive Officer, President

Veronica Vallejo

  • Chief Financial Officer
Subscribe Today!